Go to content
UR Home

Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination

URN to cite this document:
urn:nbn:de:bvb:355-epub-519726
DOI to cite this document:
10.5283/epub.51972
Bauswein, Markus ; Peterhoff, David ; Plentz, Annelie ; Hiergeist, Andreas ; Wagner, Ralf ; Gessner, André ; Salzberger, Bernd ; Schmidt, Barbara ; Bauernfeind, Stilla
Date of publication of this fulltext: 28 Mar 2022 09:43


Abstract

Heterologous SARS-CoV-2 vaccine approaches with a second mRNA-based vaccine have been favored in the recommendations of many countries over homologous vector-based ChAdOx1 nCoV-19 vaccination after reports of thromboembolic events and lower efficacy of this regimen. In the middle of 2021, the SARS-CoV-2 Delta variant of concern (VoC) has become predominant in many countries worldwide. Data ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 4239

Dissertations: dissertationen@ur.de
0941 943 3904

Research data: daten@ur.de
0941 943 4239

Contact persons